These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 9096989)

  • 1. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
    Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
    Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
    Haffner SM
    Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
    Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
    Pyörälä K; Ballantyne CM; Gumbiner B; Lee MW; Shah A; Davies MJ; Mitchel YB; Pedersen TR; Kjekshus J;
    Diabetes Care; 2004 Jul; 27(7):1735-40. PubMed ID: 15220255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).
    Pedersen TR; Olsson AG; Faergeman O; Kjekshus J; Wedel H; Berg K; Wilhelmsen L; Haghfelt T; Thorgeirsson G; Pyörälä K; Miettinen T; Christophersen B; Tobert JA; Musliner TA; Cook TJ
    Circulation; 1998 Apr; 97(15):1453-60. PubMed ID: 9576425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
    Pedersen TR; Wilhelmsen L; Faergeman O; Strandberg TE; Thorgeirsson G; Troedsson L; Kristianson J; Berg K; Cook TJ; Haghfelt T; Kjekshus J; Miettinen T; Olsson AG; Pyörälä K; Wedel H
    Am J Cardiol; 2000 Aug; 86(3):257-62. PubMed ID: 10922429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM
    Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
    Keech A; Collins R; MacMahon S; Armitage J; Lawson A; Wallendszus K; Fatemian M; Kearney E; Lyon V; Mindell J
    Eur Heart J; 1994 Feb; 15(2):255-69. PubMed ID: 8005129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
    Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
    Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
    Collins R; Armitage J; Parish S; Sleigh P; Peto R;
    Lancet; 2003 Jun; 361(9374):2005-16. PubMed ID: 12814710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction.
    Am J Cardiol; 1993 Feb; 71(5):393-400. PubMed ID: 8430625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.